VTRVentas
$82.04+23% 1Y
$82.04
$65.8452 weeks$100.56
VTR as reported
Ventas reported $6.44B of revenue over the trailing twelve months, +21% on the year before. 10 reported series are charted on this page, each one as filed.
$6.44B
Revenue, trailing twelve months · to Q2 2026 · +21% against the twelve months before
- Net income
- $273M
Net income · +37% year on year · trailing twelve months to Q2 2026
- Free cash flow
- −$2.31B
Free cash flow · +69% year on year · trailing twelve months to Q2 2026
- Operating margin
- 3.3%
Operating margin · trailing twelve months to Q2 2026
Details›
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $6.44B | +21% | Q2 2026 |
| Net income | $273M | +37% | Q2 2026 |
| EPS | $0.53 | +23% | Q2 2026 |
| Operating margin | 3.3% | n/a | Q2 2026 |
| Net margin | 4.3% | n/a | Q2 2026 |
| ROE | 2.0% | n/a | Q2 2026 |
| ROA | 0.94% | n/a | Q2 2026 |
| ROIC | 0.57% | n/a | Q2 2026 |
| Free cash flow | −$2.31B | +69% | Q2 2026 |
| P/E | 155 | n/a | today |
Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.

Ventas (VTR) · Revenue and profitRevenue and profitVentas (VTR)
RevenueNet incomeTrailing twelve months
Powered byryufin.com
REIT, Healthcare Facilities
The closest names by size in the same industry